Eton Pharmaceuticals Inc expected to post a loss of 14 cents a share - Earnings Preview

Eton Pharmaceuticals

10/05/2023 03:05

* Eton Pharmaceuticals Inc  ETON.OQ   ETON.O  is expected
to show
a rise in quarterly revenue when it reports  results on May 11. 
    * The Deer Park Illinois-based  company is expected to
report  a
109.4% increase in revenue to $4.556 million from $2.18 million
a year ago, according to the estimate from one analyst, based on
Refinitiv data. 
    * ​Refinitiv's mean analyst estimate for Eton
Pharmaceuticals Inc
is for a loss of 14 cents per share. 
    * The one available analyst rating on the shares is "buy".  
    * The mean earnings estimate of analysts was unchanged in
the last
three months. ​
    * Wall Street's median 12-month price target for Eton
Pharmaceuticals Inc is $10​, above​ its last closing price
of $3.64. ​​​

This summary was machine generated May 10 at 02:05 GMT.  All
figures in US dollars  unless otherwise stated